Papathanasiou, Theodoros
Agersø, Henrik
Damholt, Birgitte Bentz
Højby Rasmussen, Michael
Kildemoes, Rasmus Juul http://orcid.org/0000-0002-0965-9333
Clinical trials referenced in this document:
Documents that mention this clinical trial
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
https://doi.org/10.1007/s40262-021-01011-3
Documents that mention this clinical trial
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
https://doi.org/10.1007/s40262-021-01011-3
Documents that mention this clinical trial
Population Pharmacokinetics and Pharmacodynamics of Once-Daily Growth Hormone Norditropin® in Children and Adults
https://doi.org/10.1007/s40262-021-01011-3
Funding for this research was provided by:
Novo Nordisk
Article History
Accepted: 28 February 2021
First Online: 17 April 2021
Declarations
:
: Funding for this study was provided by Novo Nordisk A/S.
: Theodoros Papathanasiou and Birgitte Bentz Damholt were employees/shareholders of Novo Nordisk A/S at the time of writing. Henrik Agersø, Michael Højby Rasmussen and Rasmus Juul Kildemoes are employees/shareholders of Novo Nordisk A/S.
: All trials were approved from the local and national ethics committees and were conducted in accordance with the International Conference on Harmonisation guidelines for Good Clinical Practice [CitationRef removed] and the Declaration of Helsinki [CitationRef removed]. For children with growth hormone deficiency, parent or guardian signed informed consent was required before the initiation of any trial activity.
: Not applicable.
: Not applicable.
: The datasets generated during and/or analysed during the current study are not publicly available, but are available from the corresponding author on reasonable request.
: Not applicable.
: All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by TP and RJK. The first draft of the manuscript was written by TP and RJK, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.